Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Fosrenol lanthanum carbonate: Phase III data; approvable letter in U.S.; under EU review

In an international Phase III trial, Fosrenol improved bone histology after 12 months compared to calcium carbonate.

Read the full 171 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE